5/10
08:43 am
xbio
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
5/10
08:30 am
xbio
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
Medium
Report
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
3/22
08:07 am
xbio
Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results [Yahoo! Finance]
High
Report
Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results [Yahoo! Finance]
3/22
08:00 am
xbio
Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results
Low
Report
Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results
5/10
08:30 am
xbio
Form 8-K Xenetic Biosciences, For: May 10
Medium
Report
Form 8-K Xenetic Biosciences, For: May 10
5/9
05:01 pm
xbio
Form 10-Q Xenetic Biosciences, For: Mar 31
Medium
Report
Form 10-Q Xenetic Biosciences, For: Mar 31
4/26
04:31 pm
xbio
Form 10-K/A Xenetic Biosciences, For: Dec 31
Low
Report
Form 10-K/A Xenetic Biosciences, For: Dec 31
3/22
08:00 am
xbio
Form 8-K Xenetic Biosciences, For: Mar 22
Low
Report
Form 8-K Xenetic Biosciences, For: Mar 22
3/21
05:03 pm
xbio
Form 10-K Xenetic Biosciences, For: Dec 31
Low
Report
Form 10-K Xenetic Biosciences, For: Dec 31
3/18
01:45 pm
xbio
Form SC 13D/A Xenetic Biosciences, Filed by: CLS Therapeutics, LLC
Low
Report
Form SC 13D/A Xenetic Biosciences, Filed by: CLS Therapeutics, LLC
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
7/5
Form S-1/A Xenetic Biosciences,
39.2%
6/24
Xenetic Biosciences, Inc. Announces Reverse Stock Split of Common Stock
31.6%
8/5
Form 3 Xenetic Biosciences, For: Jul 19 Filed by: VINOGRADOV ALEXEY ANDREEVICH
9.4%
4/24
Xenetic Biosciences (XBIO) Investor Presentation - Slideshow [Seeking Alpha]
8.9%
4/2
Form 4/A Xenetic Biosciences, For: Sep 26 Filed by: Borisenko Grigory G.
5.1%
7/25
Form SC 13G Xenetic Biosciences, Filed by: Altium Capital Management LP
4.9%
1/21
Form SC 13G/A Xenetic Biosciences, Filed by: Empery Asset Management, LP
4.8%
7/29
Form SC 13D Xenetic Biosciences, Filed by: Opko Health, Inc.
4.1%
9/4
Form SC 13G Xenetic Biosciences, Filed by: SABBY MANAGEMENT, LLC
3.5%
1/13
Form SC 13G/A Xenetic Biosciences, Filed by: SABBY MANAGEMENT, LLC
3.3%
7/16
Form 8-K Xenetic Biosciences, For: Jul 16
-51.6%
7/22
Xenetic Biosciences, Inc. Closes $15.0 Million Underwritten Public Offering and Completes Acquisition of Innovative CAR T Technology Platform
-30.7%
5/15
Form S-1 Xenetic Biosciences,
-27.3%
7/22
Form 8-A12B Xenetic Biosciences,
-19.1%
7/2
Form 8-K Xenetic Biosciences, For: Jun 28
-18.8%
7/12
Form S-1/A Xenetic Biosciences,
-17.8%
7/29
Form SC 13G Xenetic Biosciences, Filed by: Anson Funds Management LP
-14.6%
2/11
Xenetic Biosciences, Inc. to Present at Noble Capital Markets' 16th Annual Investor Conference
-10.3%
10/16
Xenetic Biosciences, Inc. to Present at BIO Investor Forum
-9.7%
11/15
Xenetic Biosciences, Inc. Reports Third Quarter 2019 Financial Results and Provides Corporate Update
-9.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register